Evidence that the death receptor DR4 is a DNA damage-inducible, p53-regulated gene

被引:111
作者
Guan, BX
Yue, P
Clayman, GL
Sun, SY
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA
关键词
D O I
10.1002/jcp.1101
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
DR4 (TRAIL-R1), a member of the tumor necrosis factor receptor superfamily, is a cell surface receptor that triggers the apoptotic machinery upon binding to its: ligand tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Although three other TRAIL receptors DR5, DcR1, and DcR2 are induced by DNA damage and are regulated by the wild-type p53 tumor suppressor, it was not known whether these factors also affect DR4 expression. In this study, we found that DR4 expression is also enhanced by DNA damage whether induced by ionizing radiation or by chemotherapeutic agents. The induction was observed predominantly in cells containing wild-type p53 and was similar to the, regulation patterns of DR5 and Fas, two other members of the family which are known to be regulated by p53. Transfection of HPV 16 E6 gene into cells with wild-type p57, which decreased the level of p53 protein, resulted in suppression of DR4 induction by DNA-damaging agents. Conversely, introduction of exogenous wild-type p53 through adenovirus infection has led to upregulation of endogenous DR4 in cells with mutant p53. Moreover, the transcription inhibitor actinomycin D abolished DNA-damaging agent-induced DR4 expression. Thus, DR4 appears to be a DNA damage-inducible, p53-regulated gene. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:98 / 105
页数:8
相关论文
共 53 条
  • [1] AMEGAN EST, 1997, CELL, V89, P309
  • [2] Apoptosis control by death and decoy receptors
    Ashkenazi, A
    Dixit, VM
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1999, 11 (02) : 255 - 260
  • [3] Safety and antitumor activity of recombinant soluble Apo2 ligand
    Ashkenazi, A
    Pai, RC
    Fong, S
    Leung, S
    Lawrence, DA
    Masters, SA
    Blackie, C
    Chang, L
    McMurtrey, AE
    Hebert, A
    DeForge, L
    Koumenis, IL
    Lewis, D
    Harris, L
    Bussiere, J
    Koeppen, H
    Shahrokh, Z
    Schwall, RH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) : 155 - 162
  • [4] Death receptors: Signaling and modulation
    Ashkenazi, A
    Dixit, VM
    [J]. SCIENCE, 1998, 281 (5381) : 1305 - 1308
  • [5] Mechanisms of p53-mediated apoptosis
    Bates, S
    Vousden, KH
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 1999, 55 (01) : 28 - 37
  • [6] Buckley J. S., 1995, SPE ADV TECH SER, V3, P53, DOI [10.2118/26675-PA, DOI 10.2118/26675-PA]
  • [7] Activation-dependent transcriptional regulation of the human fas promoter requires NF-κB p50-p65 recruitment
    Chan, H
    Bartos, DP
    Owen-Schaub, LB
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1999, 19 (03) : 2098 - 2108
  • [8] To die or not to die - the quest of the TRAIL receptors
    Degli-Esposti, M
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 65 (05) : 535 - 542
  • [9] The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain
    Degli-Esposti, MA
    Dougall, WC
    Smolak, PJ
    Waugh, JY
    Smith, CA
    Goodwin, RG
    [J]. IMMUNITY, 1997, 7 (06) : 813 - 820
  • [10] Regulation of p53 downstream genes
    El-Deiry, WS
    [J]. SEMINARS IN CANCER BIOLOGY, 1998, 8 (05) : 345 - 357